Thirupathi Dongala

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Biomedical chromatography : BMC

Research square

Chromatographia

Aurex Laboratories LLC

GITAM University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aurex Laboratories LLC

United States

Analytical scientist-I :: Quality Control

Aurex Laboratories Pvt. Ltd

India

Deputy Manager :: Analytical Reserch and Development

Dr Reddy's Laboratories Ltd Jul 02 2007 - Aug 19 2016

India

Scientist :: Analytical Reserch and Development

Education History

GITAM University Jun 01 2017

India

PHD :: Chemistry

Sri Venkateswara University

India

MSC :: Analytical Chemistry

Publications

Santhosh Kumar Ettaboina, Satyasree Nannapaneni, Nagalakshmi Jeedimalla, Thirupathi Dongala, Siva Krishna Muchakayala, Naresh Kumar Katari
Development, evaluation of critical method variables and stability assessment using a Box-Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone. Biomedical chromatography : BMC (2024)
Ravindra Mallavarapu, Naresh Kumar Katari, Thirupathi Dongala, Vijay Kumar Rekulapally, Vishnu Murthy Marisetti, Govind Vyas
A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms. Biomedical chromatography : BMC (2021)
Ravindra Mallavarapu, Naresh Kumar Katari, Thirupathi Dongala, Krishnan Anand, Vishnu Murthy Marisetti
Low-level determination of 4-chlorobutyl-(S)-[4-chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxy-but-3yn-2-yl)phenyl] carbamate (4-CTHC) in efavirenz drug substance by LC-MS. Biomedical chromatography : BMC 35 (7) (2021)
Parvateesam Yenda, Naresh Kumar Katari, Thirupathi Dongala, Govind Vyas, Lakshmi Narasimha Rao Katakam, Santhosh Kumar Ettaboina
A simple isocratic LC method for quantification of trace-level inorganic degradation impurities (ferricyanide, ferrocyanide, nitrite, and nitrate) in sodium nitroprusside injection and robustness by quality using design approach. Biomedical chromatography : BMC (2021)
Velusamy B Subramanian, Naresh Kumar Katari, Vijetha Ponnam, Naresh Konduru, Thirupathi Dongala, Vishnu M Marisetti, Govind Vyas
Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach. Biomedical chromatography : BMC (2021)
Lakshmi Narasimha Rao Katakam, Thirupathi Dongala, Santhosh Kumar Ettaboina
Quality by design with design of experiments approach for development of a stability-indicating LC method for enzalutamide and its impurities in soft gel dosage formulation. Biomedical chromatography : BMC 35 (5) (2021)
Lakshmi Narasimha Rao Katakam, Thirupathi Dongala
A novel RP-HPLC refractive index detector method development and validation for determination of trace-level alcohols (un-sulfated) in sodium lauryl sulfate raw material. Biomedical chromatography : BMC 34 (7) (2020)
Thirupathi Dongala, Santhosh Kumar Ettaboina, Naresh Kumar Katari
A Novel RP-HPLC-DAD Method Development for Anti-Malarial and COVID-19 Hydroxy Chloroquine Sulfate Tablets and Profiling of In-Vitro Dissolution in Multimedia. Research square (2020)
Thirupathi Dongala, Naresh Kumar Katari, Ashok Kumar Palakurthi, Lakshmi Narasimha Rao Katakam, Vishnu Murthy Marisetti
Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach. Chromatographia (2020)
Ashok Kumar Palakurthi, Thirupathi Dongala, Ravindra Kumar Yalavarthi, Jayashree Anireddy
QbD-based development of an extraction procedure for simultaneous quantification of telmisartan, amlodipine besylate and chlorthalidone in combination complex matrix formulation. Biomedical chromatography : BMC 34 (2) (2020)
Thirupathi Dongala, Naresh Kumar Katari, Ashok Kumar Palakurthi, Sreekantha Babu Jonnalagadda
Development and validation of a generic RP-HPLC PDA method for the simultaneous separation and quantification of active ingredients in cold and cough medicines. Biomedical chromatography : BMC 33 (11) (2019)
Velusamy B Subramanian, Naresh Kumar Katari, Thirupathi Dongala, Sreekantha Babu Jonnalagadda
Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach. Biomedical chromatography : BMC 34 (1) (2019)
Thirupathi Dongala, Naresh Kumar Katari, Ashok Kumar Palakurthi, Sreekantha B Jonnalagadda
Stability-indicating HPLC method for simultaneous quantification of 14 impurities in excedrin tablet formulations and identification of new impurity by LC-MS in accelerated stability studies. Biomedical chromatography : BMC 33 (10) (2019)

Thirupathi Dongala.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thirupathi Dongala